Agios Pharmaceuticals, Inc. (AGIO) Cash Flow Statement
Agios Pharmaceuticals, Inc. (AGIO) generated -$360.6M of operating cash flow over the twelve months to 2026-06-30, spent $4.7M on capital expenditure and had free cash flow of -$365.3M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AGIOAgios Pharmaceuticals, Inc.Follow AGIO — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.06 | -0.06 | -0.08 | 0.04 | -0.29 | -0.30 | -0.37 | -0.31 | -0.30 | -0.39 | -0.37 | -0.36 | |
| Capital expenditure | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | -0.06 | -0.06 | -0.10 | 0.03 | -0.29 | -0.31 | -0.38 | -0.31 | -0.30 | -0.39 | -0.38 | -0.37 | |
| Stock-based compensation | 0.00 | 0.01 | 0.03 | 0.04 | 0.05 | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 | — |
USD billions · SEC XBRL
Agios Pharmaceuticals, Inc. — questions
- What is Agios Pharmaceuticals, Inc.'s operating cash flow?
- -$360.6M over the twelve months to 2026-06-30.
- How much does Agios Pharmaceuticals, Inc. spend on capital expenditure?
- $4.7M over the twelve months to 2026-06-30.
- What is Agios Pharmaceuticals, Inc.'s free cash flow?
- -$365.3M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Agios Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.